Status:
ENROLLING_BY_INVITATION
Development & Clinical Application of K-PaC Registry Version 2.0
Lead Sponsor:
National Cancer Center, Korea
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
19+ years
Brief Summary
Development and clinical use of pancreatic cancer registry * Development of K-PaC Registry v.2.0: Retrospective data integration from 2010 to 2022 and prospective data collection from more than 811 e...
Detailed Description
We plan to collect retrospective and prospective data based on medical data centered on EMR. ∙ This registry is built on EMR data containing specific information on medical provider records and patien...
Eligibility Criteria
Inclusion
- Clinical diagnosis of pancreatic cancer
Exclusion
- In cases where medical record review is not feasible
Key Trial Info
Start Date :
January 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
6923 Patients enrolled
Trial Details
Trial ID
NCT07171515
Start Date
January 2 2023
End Date
December 31 2030
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center
Goyang, Gyeonggido, South Korea, 10408